Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,197,926 | 1,126,107 | 1,045,712 | 897,841 | 1,088,173 |
| Cost of Goods | 153,528 | 128,880 | 116,268 | 104,620 | 128,713 |
| Gross Profit | 1,044,398 | 997,227 | 929,444 | 793,221 | 959,460 |
| Operating Expenses | 790,391 | 940,598 | 1,616,104 | 849,733 | 769,403 |
| Operating Income | 254,535 | 57,509 | -686,392 | -55,892 | 190,770 |
| Interest Expense | 45,406 | 48,576 | 47,363 | 53,706 | 51,256 |
| Other Income | -715 | 55 | -1,885 | -755 | -6,311 |
| Pre-tax Income | 208,414 | 8,988 | -735,640 | -110,353 | 133,203 |
| Income Tax | 4,963 | -242,424 | -17,170 | -17,812 | -57,912 |
| Net Income Continuous | 203,451 | 251,412 | -718,470 | -92,541 | 191,115 |
| Net Income | $203,451 | $251,412 | $-718,470 | $-92,541 | $191,115 |
| EPS Basic Total Ops | 3.28 | 4.14 | -11.74 | -1.52 | 3.11 |
| EPS Basic Continuous Ops | 3.28 | 4.14 | -11.74 | -1.52 | 3.11 |
| EPS Diluted Total Ops | 3.34 | 4.08 | -11.74 | -1.52 | 2.97 |
| EPS Diluted Continuous Ops | 3.34 | 4.08 | -11.74 | -1.52 | 2.89 |
| EPS Diluted Before Non-Recurring Items | 5.76 | 6.99 | -9.07 | 0.60 | 5.70 |
| EBITDA(a) | $433,704 | $235,755 | $-512,383 | $108,981 | $359,187 |